PT2854765T - Solução farmacêutica de pemetrexede - Google Patents
Solução farmacêutica de pemetrexedeInfo
- Publication number
- PT2854765T PT2854765T PT13737527T PT13737527T PT2854765T PT 2854765 T PT2854765 T PT 2854765T PT 13737527 T PT13737527 T PT 13737527T PT 13737527 T PT13737527 T PT 13737527T PT 2854765 T PT2854765 T PT 2854765T
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical
- pemetrexed solution
- pemetrexed
- solution
- pharmaceutical pemetrexed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102012010774A DE102012010774A1 (de) | 2012-05-31 | 2012-05-31 | Pharmazeutische Pemetrexed-Lösung |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2854765T true PT2854765T (pt) | 2019-06-25 |
Family
ID=48793847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT13737527T PT2854765T (pt) | 2012-05-31 | 2013-05-29 | Solução farmacêutica de pemetrexede |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2854765B1 (pt) |
KR (2) | KR101843613B1 (pt) |
DE (1) | DE102012010774A1 (pt) |
DK (1) | DK2854765T3 (pt) |
ES (1) | ES2731526T3 (pt) |
HR (1) | HRP20191016T1 (pt) |
PL (1) | PL2854765T3 (pt) |
PT (1) | PT2854765T (pt) |
WO (1) | WO2013178214A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101260636B1 (ko) * | 2012-11-29 | 2013-05-13 | 씨제이제일제당 (주) | 안정화된 페메트렉시드 제제 |
RS60183B1 (sr) | 2014-10-16 | 2020-06-30 | Synthon Bv | Tečna farmaceutska kompozicija koja sadrži pemetreksed |
WO2016159684A1 (ko) * | 2015-04-01 | 2016-10-06 | 주식회사 아모레퍼시픽 | 소듐 2-메르캅토에탄 설포네이트를 함유하는 피부 재생 촉진용 조성물 |
KR101693675B1 (ko) | 2015-12-14 | 2017-01-06 | 주식회사 종근당 | 페메트렉시드 또는 그의 약제학적으로 허용가능한 염을 함유하는 안정화된 약학조성물 |
US20170239250A1 (en) * | 2016-02-19 | 2017-08-24 | Eagle Pharmaceuticals, Inc. | Pemetrexed formulations |
KR102040034B1 (ko) | 2017-12-13 | 2019-11-05 | 주식회사 아이큐어비앤피 | 페메트렉시드를 포함하는 경구용 약학 조성물 및 이의 제조방법 |
EP4046626A1 (de) | 2021-02-21 | 2022-08-24 | STADA Arzneimittel AG | Verwendung einer pemetrexed-konzentratlösung |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL150475A0 (en) | 2000-02-04 | 2002-12-01 | Lilly Co Eli | Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid |
WO2012015810A2 (en) | 2010-07-28 | 2012-02-02 | Eagle Pharmaceuticals, Inc. | Pharmaceutical compositions containing pemetrexed having extended storage stability |
KR20130122065A (ko) * | 2012-04-30 | 2013-11-07 | 씨제이제일제당 (주) | 페메트렉시드를 함유하는 안정화된 주사용 액상 제제 |
KR101260636B1 (ko) | 2012-11-29 | 2013-05-13 | 씨제이제일제당 (주) | 안정화된 페메트렉시드 제제 |
-
2012
- 2012-05-31 DE DE102012010774A patent/DE102012010774A1/de not_active Ceased
-
2013
- 2013-05-29 KR KR1020147031312A patent/KR101843613B1/ko active IP Right Grant
- 2013-05-29 PT PT13737527T patent/PT2854765T/pt unknown
- 2013-05-29 KR KR1020177021453A patent/KR102004341B1/ko active IP Right Grant
- 2013-05-29 WO PCT/DE2013/000292 patent/WO2013178214A1/de active Application Filing
- 2013-05-29 PL PL13737527T patent/PL2854765T3/pl unknown
- 2013-05-29 ES ES13737527T patent/ES2731526T3/es active Active
- 2013-05-29 DK DK13737527.5T patent/DK2854765T3/da active
- 2013-05-29 EP EP13737527.5A patent/EP2854765B1/de active Active
-
2019
- 2019-06-04 HR HRP20191016TT patent/HRP20191016T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
DK2854765T3 (da) | 2019-07-01 |
KR20170091778A (ko) | 2017-08-09 |
EP2854765A1 (de) | 2015-04-08 |
PL2854765T3 (pl) | 2019-11-29 |
EP2854765B1 (de) | 2019-03-27 |
KR20150020266A (ko) | 2015-02-25 |
KR102004341B1 (ko) | 2019-07-26 |
HRP20191016T1 (hr) | 2019-08-23 |
KR101843613B1 (ko) | 2018-03-29 |
WO2013178214A1 (de) | 2013-12-05 |
ES2731526T3 (es) | 2019-11-15 |
DE102012010774A1 (de) | 2013-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2832453A4 (en) | ATOMIZERS | |
ZA201501930B (en) | Pharmaceutical composition | |
PL2870072T3 (pl) | Dozownik leków | |
EP2832730A4 (en) | MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION | |
HK1205146A1 (en) | Pharmaceutical formulation | |
PL2854765T3 (pl) | Farmaceutyczny roztwór pemetreksedu | |
GB201205164D0 (en) | Pharmaceutical compounds | |
IL235131A0 (en) | dispenses medicine | |
HK1210718A1 (en) | Antitrichophytosis solution for external use | |
EP2883547A4 (en) | MEDICINE | |
EP2731610A4 (en) | PHARMACEUTICAL COMBINATION | |
HK1215789A1 (zh) | 藥物組合 | |
GB201220632D0 (en) | Medication container | |
HK1216619A1 (zh) | 藥物化合物 | |
GB201218012D0 (en) | Dosage forms | |
ZA201502987B (en) | Pharmaceutical composition | |
IL235539A0 (en) | liquid sprayer | |
EP2897590A4 (en) | PHARMACEUTICAL COMPOSITION | |
AP3822A (en) | Oxidizer solution | |
GB201202027D0 (en) | Pharmaceutical compounds | |
IL220794A (en) | Medication dispenser | |
EP2851078A4 (en) | PHARMACEUTICAL COMPOSITION | |
GB201219236D0 (en) | Pharmaceutical compounds | |
GB201214121D0 (en) | Pharmaceutical compounds | |
GB201213519D0 (en) | Pharmaceutical compounds |